Morning symptoms
Association between morning symptoms and physical activity in COPD: a systematic review
12
<p>The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD</p>
9
Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
8
The association between objectively measured physical activity and morning symptoms in COPD
10
Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms
9
Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease
10
Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI)
13
Evaluation of Psychological Score and Quality of Life in Adults with Allergic Rhinitis and Assessment of Related Risk Factors
7
Symptom variability in COPD: a narrative review
8
Glucocorticoids and chronotherapy in rheumatoid arthritis
9
Chronic obstructive pulmonary disease : new insights in morning symptons and physical activity
178
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)
10
<p>Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study</p>
13
Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
7
Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study
13
COPD symptoms in the morning: impact, evaluation and management
8
Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study
11
Visual analogue scale (VAS) as a monitoring tool for daily changes in asthma symptoms in adolescents: a prospective study
8
CHRONOTHERAPEUTICS DRUG DELIVERY SYSTEMS CHALLENGES TO PHARMACEUTICAL FIELD
11
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
12